Zusammenfassung
Die Gynäkomastie ist eine mögliche Behandlungsnebenwirkung bei der Hormontherapie im Rahmen der Behandlung des Prostatakarzinoms. Im Rahmen großer randomisierter kontrollierter Studien wurde bei ca. 50% der Männer mit Prostatakarzinom eine Gynäkomastie auf Grundlage verschiedener Mechanismen gefunden. Obwohl die Ausprägung der Gynäkomastie meist als mild bis moderat beschrieben wird, zählt sie jedoch zu den häufigsten Abbruchgründen einer solchen Therapie. Die Möglichkeit der Radiotherapie und der medikamentösen Therapie durch Tamoxifen führte zu einer Reduktion der Gynäkomastierate, es verbleiben jedoch immer noch viele therapieresistente Patienten, die eine plastisch-chirurgische Korrektur dieser Nebenwirkung benötigen.
Die Gynäkomastie ist eine benigne Vergrößerung der männlichen Brustdrüse und benötigt per se keine Behandlung, es sei denn, es besteht eine stigmatisierende und dadurch für den Patienten belastende Vergrößerung. Die Indikation für die chirurgische Behandlung der Gynäkomastie basiert auf zwei wesentlichen Punkten: der Rekonstruktion der männlichen Brust- und Thoraxform und der diagnostischen Evaluation suspekter Brustläsionen. Bei der chirurgischen Technik halten wir die komplette zirkumareoläre Technik ohne weitere Narben für die ästhetisch am besten geeignete Prozedur. In Kombination mit einer Fettabsaugung kann ein harmonisches und ästhetisch ansprechendes Ergebnis erzielt werden.
Abstract
Gynecomastia is a potential side effect of hormone therapy for prostate cancer. In large, randomized, placebo controlled studies approximately 50% or more of patients with prostate cancer experienced gynecomastia attributable to various mechanisms. Although it is mostly reported as mild to moderate, gynecomastia is one of the reasons most frequently cited for premature discontinuation of such treatment. Prophylactic radiotherapy and prophylactic tamoxifen have been shown to decrease the incidence of hormone-induced gynecomastia; nevertheless, there are still cases of refractory gynecomastia, and in these plastic surgery is needed for correction.
Gynecomastia is a benign enlargement of the male breast, requiring no treatment unless it is a source of embarrassment and/or distress for the adolescent or man affected. The indications for surgical treatment of gynecomastia are founded on two main objectives: restoration of the male chest shape and diagnostic evaluation of suspected breast lesions. The authors believe that the complete circumareolar technique with no further scarring creates the best aesthetic results with fewer complications. When this is used in combination with liposuction very pleasing aesthetic results can be achieved.
Literatur
Abramo AC (1994) Axillary approach for gynecomastia liposuction. Aesthetic Plast Surg 18: 265–268
Aegineta, P (1846) On male breast resembling the female. In: Adams F (ed) The seven books of Paulus Aegineta. Vol. 2, Book 6, Section 46. Sydenham Society, London, pp 334–335
Andel G van, Kurth KH (2003) The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. Eur Urol 44: 209–214
Andersen JA, Gram JB (1982) Male breast at autopsy. Acta Pathol Microbiol Immunol Scand (A) 90: 191–197
Benelli (1990) A new periareolar mammaplasty: the „round block“ technique. Aesthetic Plast Surg 14: 93–100
Botta SA (1998) Alternatives for the surgical correction of severe gynecomastia. Aesthetic Plast Surg 22: 65–70
Braunstein GD (1993) Gynecomastia. N Engl J Med 328: 490–495
Brenner P, Berger A, Schneider W, Axmann HD (1992) Male reduction mammoplasty in serious gynecomastias. Aesthetic Plast Surg 16: 325–330
Castro-Magana M, Angulo M, Uy J (1993) Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 328: 1297–1301
Chodak G, Sharifi R, Kasimis B et al. (1995) Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology 46: 849–855
Cianchetti E, Legnini M, Ucchino S et al. (1996) Ginecomastia. Ann Ital Chir 67: 495–500
Denis LJ, Keuppens F, Smith PH et al. (1998) Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur Urol 33: 144–151
Fruhstorfer BH, Malata CM (2003) A systematic approach to the surgical treatment of gynaecomastia. Br J Plast Surg 56: 237–246
Green HJ, Pakenham KI, Headley BC, Gardiner RA (2002) Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring. Psychooncology 11: 401–414
Hedlund PO, Henriksson P (2000) Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study. Urology 55: 328–333
Hertl MC, Wiebel J, Schafer H et al. (1998) Feminizing Sertoli cell tumors associated with Peutz-Jeghers syndrome: an increasingly recognized cause of prepubertal gynecomastia. Plast Reconstr Surg 102: 1151–1157
Iversen P, Tyrrell CJ, Kaisary AV et al. (2000) Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 164: 1579–1582
Kornstein AN, Cinelli PB (1992) Inferior pedicle reduction technique for larger forms of gynecomastia. Aesthetic Plast Surg 16: 331–335
Liebau J, Machens HG, Berger A (1998) Gynecomastia of the male nipple. Ann Plast Surg 40: 678–691
Morselli PG (1996) „Pull-through“: a new technique for breast reduction in gynecomastia. Plast Reconstr Surg 97: 450–454
Murphy TP, Ehrlichman RJ, Seckel BR (1994) Nipple placement in simple mastectomy with free nipple grafting for severe gynecomastia. Plast Reconstr Surg 94: 818–823
Nicolis GL, Modlinger RS, Gabrilove JL (1971) A study of the histopathology of human gynecomastia. J Clin Endocrinol Metab 32: 173–178
Ockrim JL, Lalani E-N, Laniado ME et al. (2003) Transdermal estradiol therapy for advanced prostate cancer – forward to the past? J Urol 169: 1735–1737
Ohyama T, Takada A, Fujikawa M, Hosokawa K (1998) Endoscope-assisted transaxillary removal of glandular tissue in gynecomastia. Ann Plast Surg 40: 62–64
Peled IJ (1991) The concentric mastopexy and purse-string suture. Plast Reconstr Surg 87: 385
Physicians‘ Desk Reference (2003) Montvale: Medical Economics
Rohrich RJ, Ha RY, Kenkel JM, Adams WP Jr (2003) Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 111: 909–923
Samdal F, Kleppe G, Amland PF, Abyholm F (1994) Surgical treatment of gynaecomastia: Five years’ experience with liposuction. Scand J Plast Reconstr Surg Hand Surg 28: 123–130
Simon BE, Hoffman S, Kahn S (1973) Classification and surgical correction of gynecomastia. Plast Reconstr Surg 51: 48–52
Smoot EC III (1998) Eccentric skin resection and purse-string closure for skin reduction with mastectomy for gynecomastia. Ann Plast Surg 41: 378–383
Smyth CM, Bremner WJ (1998) Klinefelter syndrome. Arch Intern Med 158: 1309–1314
Stark GB, Grandel S, Spilker G (1992) Tissue suction of the male and female breast. Aesthetic Plast Surg 16: 317–324
Teimourian B, Perlman R (1983) Surgery for gynecomastia. Aesthetic Plast Surg 7: 155–157
Waterfall NB, Glaser MG (1979) A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy. Clin Oncol 5: 257–260
Webster JP (1946) Mastectomy for gynecomastia through a semicircular intra-areolar incision. Ann Surg 124: 557–575
Widmark A, Fossa SD, Lundmo P et al. (2003) Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 61: 145–151
Williams MJ (1963) Gynecomastia: Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med 34: 103–112
Wilson JD, Aiman J, MacDonald PC (1980) The pathogenesis of gynecomastia. Adv Intern Med 25: 1–32
Wortsman J, Hamidinia A, Winters SJ (1989) Hypogonadism following long-term treatment with diethylstilbestrol. Am J Med Sci 297: 365–368
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ryssel, H., Germann, G., Köllensperger, E. et al. Die plastische chirurgische Therapie der Gynäkomastie nach antihormoneller Therapie bei Prostatakarzinom. Urologe 47, 467–471 (2008). https://doi.org/10.1007/s00120-007-1567-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-007-1567-3
Schlüsselwörter
- Prostatakarzinom
- Hormontherapie
- Gynäkomastie
- Plastisch-chirurgische Korrektur
- Zirkumareoläre Technik
- Fettabsaugung